From the CIA to Agentic AI: Bennett Borden on AI Adoption in Healthcare

AI is no longer just writing emails, summarizing documents, or answering questions. The rise of agentic AI is transforming how organizations make decisions, automate workflows, manage risk, and deliver services - especially in highly regulated industries such as healthcare, biotechnology, pharmaceuticals, and hospital systems. In this episode of Rx for Biotech, host Chris Leidli sits down with Bennet Borden, lawyer, data scientist, and founder of Clarion AI, an AI-native legal and technology consultancy, to explore why this next wave of artificial intelligence could fundamentally reshape the future of professional services and healthcare. Bennet brings an unusual perspective to the AI revolution. His career spans intelligence analytics, leading global law firms, AI governance, enterprise technology, and the development of AI-powered systems. As AI moves from generating content to taking action, healthcare organizations face a new challenge: How do you safely deploy AI systems that make recommendations, perform tasks, and influence decisions affecting real people? Bennet explains why successful AI transformation requires that organizations rethink workflows, how to unlock proprietary data, develop specialized AI agents, and build governance directly into their systems. And perhaps most importantly, they must understand that AI transformation is as much about people as technology. In this episode, we discuss: • Generative AI vs. agentic AI: Why moving from generating content to performing tasks changes everything. • AI and the future of law: The analysis of 14,000 attorneys and why traditional professional services are facing disruption. • Agentic AI in healthcare: Opportunities for medical documentation, clinical decision support, diagnostic workflows, and patient services. • AI governance and compliance: How pharmaceutical companies and hospital systems can manage AI risk, safety, accountability, and regulatory uncertainty. • The AI black-box problem: Why measuring what AI systems actually do matters more than debating how they work internally. • Build vs. buy: Why general-purpose AI tools may deliver productivity improvements but not lasting competitive differentiation. • Enterprise data and AI agents: How organizations can leverage internal knowledge and expertise through specialized agentic workflows. • AI transformation and change management: Why Bennet describes transformation as 20% technology and 80% psychology. • Human expertise and AI augmentation: Why the goal should be Iron Man, not the Terminator. • AI vendor contracts: What healthcare and life sciences organizations should consider when evaluating accountability, indemnification, and risk allocation. • The future of AI in healthcare: Why the human relationship between patients and clinicians remains essential. Whether you are a biotechnology executive, pharmaceutical leader, clinician, hospital administrator, attorney, AI developer, or investor, this conversation offers a practical perspective on adopting artificial intelligence responsibly while remaining competitive. Connect with Bennet Borden at Clarion AI Partners Website: https://clarionailaw.com About "Rx for Biotech" Podcast Rx for Biotech explores how biotechnology, artificial intelligence, precision medicine, and advanced therapies are transforming healthcare. Hosted by Chris Leidli, Founder and CEO of Genoplex, the podcast features conversations with executives, physicians, scientists, and innovators building the future of medicine. Subscribe to Rx for Biotech for more conversations on agentic AI, biotechnology innovation, healthcare technology, personalized medicine, and patient access. This episode is intended for educational and informational purposes and does not constitute legal, regulatory, or medical advice.